Nov 4, 2026
1-day lag
Exercise
Nov 3, 2026
Stock option (right to buy) on Common Stock
Maduck Sean
Other
13,159 shares @ $0
Direct ownership
$0
SEC Form 4
›
Same filing as the row above
Sale
Nov 3, 2026
Common Stock
4,542 shares @ $82.68
Direct ownership
$375.51K
›
Same filing as the row above
Exercise
Nov 3, 2026
13,159 shares @ $8.27
Direct ownership
$108.82K
›
Same filing as the row above
Sale
Nov 2, 2026
11,841 shares @ $81.42
Direct ownership
$964.07K
›
Same filing as the row above
Exercise
Nov 2, 2026
Stock option (right to buy) on Common Stock
11,841 shares @ $0
Direct ownership
$0
›
Same filing as the row above
Exercise
Nov 2, 2026
Common Stock
11,841 shares @ $8.27
Direct ownership
$97.93K
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Common Stock
Kleinerman Christian
EVP, Product Management
10,000 shares @ $306.01
Direct ownership
$3.06M
SEC Form 4
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Common Stock
Vieira Roberto Wandenkolk
President, Oncology
6,657 shares @ $80.73
Direct ownership
$537.44K
SEC Form 4
›
Same filing as the row above
Exercise
Nov 2, 2026
8,333 shares @ $21.63
Direct ownership
$180.24K
›
Same filing as the row above
Sale
Nov 2, 2026
1,676 shares @ $81.52
Direct ownership
$136.63K
›
Same filing as the row above
Exercise
Nov 2, 2026
Stock option (right to buy) on Common Stock
8,333 shares @ $0
Direct ownership
$0
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Class A-1 Common Stock
Phelan Mark T.
President And CEO
25,000 shares @ $12
Direct ownership
$300K
SEC Form 4
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Common Stock
Anschutz Barron
Other
10,000 shares @ $51
Direct ownership
$510K
SEC Form 4
›
Nov 4, 2026
2-day lag
Exercise
Nov 2, 2026
Stock Option (right to buy) on Common Stock
Seawell A Brooke
Director
115,000 shares @ $0
Direct ownership
$0
SEC Form 4
›
Same filing as the row above
Sale
Nov 2, 2026
Common Stock
15,000 shares @ $48.73
Indirect ownership
$730.95K
›
Same filing as the row above
Sale
Nov 2, 2026
15,000 shares @ $50.33
Direct ownership
$754.95K
›
Same filing as the row above
Exercise
Nov 2, 2026
115,000 shares @ $9.66
Direct ownership
$1.11M
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Common Stock
Bales Brian A
EVP, Chief Development Officer
3,400 shares @ $244
Indirect ownership
$829.6K
SEC Form 4
›
Nov 4, 2026
5-day lag
Award
Oct 30, 2026
Common Stock
Tkachenko Igor
VP, Corporate Strategy
15,419 shares @ $0
Direct ownership
$0
SEC Form 4
›
Nov 4, 2026
2-day lag
Award
Nov 2, 2026
Performance Right on Common Stock
Honroth Eric
President And CEO
62,928 shares @ $0
Direct ownership
$0
SEC Form 4
›
Same filing as the row above
Award
Nov 2, 2026
Common Stock
38,265 shares @ $0
Direct ownership
$0
›
Same filing as the row above
Award
Nov 2, 2026
62,928 shares @ $0
Direct ownership
$0
›
Nov 4, 2026
2-day lag
Conversion
Nov 2, 2026
Series A-2 Convertible Preferred Stock on Com...
Thompson Peter A.
Director / Ten Percent Owner
616,984 shares @ $0
Indirect ownership
$0
SEC Form 4
›
Same filing as the row above
Conversion
Nov 2, 2026
Series A-1 Convertible Preferred Stock on Common Stock
642,745 shares @ $0
Indirect ownership
$0
›
Same filing as the row above
Conversion
Nov 2, 2026
Common Stock
196,541 shares
Indirect ownership
Not reported
›